阿戈美拉汀联合右佐匹克隆治疗卒中相关睡眠障碍的疗效观察(3)
[5]V.E.Medvedev，Perspectives in the use of melatoninergic agents in the treatment of depression in patients with cardiovascular diseases[J].Psikhiatr Psikhofarmakoter，2010，3：17-22.
[6]Kim K T，Moon H J，Yang J G，et al.The prevalence and clinical significance of sleep disorders in acute ischemic stroke patients-a questionnaire study[J].Sleep Breath，2017，21(3)：759-765.
[7]Gudberg C，Johansen Berg H.Sleep and motor learning：Implications for physical rehabilitation after stroke[J].Front Neurol，2015，6：241.
[8]Xiu-Quan Li.Effects of dexzopiclone and estazolam on neurotransmitters，nerve cytokines and stress states in patients with insomnia after stroke[J].Journal of Hainan Medical University，2018，11：80-83.
[9]Fei-yi Zhao，Ying-xia Zhao，Hai-xia Yan，et al.Auricular acupressure as assistant in primary insomnia management：a randomized single-blind controlled clinical trial[J].Journal of Acupuncture and Tuina Science，2019，1：49-55.
[10]Millan MJ，Brocco M，Gobert A，et al.Anxiolytic properties of agomalatine，an antidepre-ssant with melatoninergic and serotonergic properties：role of 5-HT2c receptor blockade[J].Psychopharmacology(Ber1)，2005，177(4)：448-458.
[11]A.N.Bogolepova，E.I.Chukanova，M.Yu.Smirnova，et al.Experience in the Use of Valdoxan in the Treatment of Post-Stroke Depression[J].Neuroscience and Behavioral Physiology，2012，6：556-560., 百拇医药(李红闪 李轩 赵婧)
[6]Kim K T，Moon H J，Yang J G，et al.The prevalence and clinical significance of sleep disorders in acute ischemic stroke patients-a questionnaire study[J].Sleep Breath，2017，21(3)：759-765.
[7]Gudberg C，Johansen Berg H.Sleep and motor learning：Implications for physical rehabilitation after stroke[J].Front Neurol，2015，6：241.
[8]Xiu-Quan Li.Effects of dexzopiclone and estazolam on neurotransmitters，nerve cytokines and stress states in patients with insomnia after stroke[J].Journal of Hainan Medical University，2018，11：80-83.
[9]Fei-yi Zhao，Ying-xia Zhao，Hai-xia Yan，et al.Auricular acupressure as assistant in primary insomnia management：a randomized single-blind controlled clinical trial[J].Journal of Acupuncture and Tuina Science，2019，1：49-55.
[10]Millan MJ，Brocco M，Gobert A，et al.Anxiolytic properties of agomalatine，an antidepre-ssant with melatoninergic and serotonergic properties：role of 5-HT2c receptor blockade[J].Psychopharmacology(Ber1)，2005，177(4)：448-458.
[11]A.N.Bogolepova，E.I.Chukanova，M.Yu.Smirnova，et al.Experience in the Use of Valdoxan in the Treatment of Post-Stroke Depression[J].Neuroscience and Behavioral Physiology，2012，6：556-560., 百拇医药(李红闪 李轩 赵婧)